Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in <i>TP53</i> Mutated Ultra High-Risk Neuroblastoma Cell Line...

by Linnéa Ödborn Jönsson, Maryam Sahi, Ximena Lopez-Lorenzo, Faye Leilah Keller, Ourania N. Kostopoulou, Nikolas Herold, Lars Ährlund-Richter, Shahrzad Shirazi Fard
Published 2021-04-01